Acalabrutinib

Acalabrutinib is a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It belongs to a class of drugs known as Bruton’s tyrosine kinase (BTK) inhibitors, which help slow cancer cell growth. Acalabrutinib is often prescribed for patients who cannot tolerate other treatments or for those with relapsed or refractory cancer. It is taken orally and is known for its effectiveness in managing blood cancers with fewer side effects than traditional chemotherapy.

Uses of Acalabrutinib

• Treatment of chronic lymphocytic leukemia (CLL)
• Management of small lymphocytic lymphoma (SLL)
• Treatment of mantle cell lymphoma (MCL)
• Used in patients with relapsed or refractory blood cancers

How Acalabrutinib Works

Acalabrutinib works by blocking Bruton’s tyrosine kinase (BTK), an enzyme that promotes the growth and survival of cancerous B cells. By inhibiting BTK, Acalabrutinib prevents cancer cells from multiplying and spreading, effectively slowing disease progression.

Benefits of Acalabrutinib

• Specifically targets cancerous B cells
• Fewer side effects compared to chemotherapy
• Effective in patients with relapsed or refractory cancers
• Can be used alone or in combination with other cancer treatments

How to Take Acalabrutinib

Acalabrutinib is taken orally, usually as a 100 mg capsule twice daily. It should be swallowed whole with water and not chewed or crushed. It is best taken at the same time each day, with or without food. Follow the doctor’s prescription carefully and avoid missing doses.

Types of Dosage Available

• 100 mg oral capsules

Side Effects of Acalabrutinib

• Headache and dizziness
• Fatigue and weakness
• Diarrhea and stomach discomfort
• Increased risk of infections
• Bruising and bleeding issues
• Heart rhythm problems

Safety Advice

• Avoid grapefruit or grapefruit juice while taking Acalabrutinib
• Inform your doctor if you have heart disease or bleeding disorders
• Do not take with strong CYP3A inhibitors or inducers
• Monitor for signs of infection or unusual bleeding
• Not recommended for pregnant or breastfeeding women

Frequently Asked Questions (FAQs)

Q: What is Acalabrutinib used for?
A: Acalabrutinib is used to treat chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).

Q: How long does Acalabrutinib take to work?
A: The effects vary, but some patients notice improvement within weeks, while full benefits may take months.

Q: Can Acalabrutinib be taken with food?
A: Yes, Acalabrutinib can be taken with or without food.

Q: What should I avoid while taking Acalabrutinib?
A: Avoid grapefruit and certain medications that interact with Acalabrutinib.

Q: Where can I buy Acalabrutinib?
A: You can buy Acalabrutinib from Zeelab Pharmacy at the best price.